ThursdayJul 01, 2021 10:28 am

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Announces New COO, New Board Member

Healthtech Solutions (OTC: HLTT), an innovative portfolio-model life sciences company focused on building impactful solutions for patients and the healthcare system through its subsidiary companies ranging in stage from preclinical to commercial growth, has named Brad Mathis as its new chief operating officer and Ryan Salomone as a new member of the company’s board of directors. Mathis and Salomone have decades of experience in the healthcare, pharmaceutical and biotech industries, and their appointments broaden the company’s leadership teams. Mathis comes from Argenx Inc., where he most recently served as vice president and general manager of the company’s US Neurology franchise;…

Continue Reading

ThursdayJun 24, 2021 1:26 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Positioning at Leading Edge of Cancer Treatment

Healthtech Solutions (OTC: HLTT) is positioning itself to be a leader in the burgeoning precision oncology market — projected to grow at a 9.9% CAGR from 2019 to 2027 and reach an estimated $99.7 billion — as a result of its newest acquisition: Varian Biopharmaceuticals. Varian is a precision oncology company developing novel therapeutics for the treatment of cancer — a proprietary atypical protein kinase C iota (“aPKCi”) inhibitor for the treatment of various tumor types. Its drug candidates, VAR-101 and VAR-102, leverage the company’s expertise. According to HLTT chairman David Rubin, who was quoted by a recent article, “Varian…

Continue Reading

ThursdayJun 17, 2021 10:33 am

Healthtech Solutions Inc. (HLTT) Initiates Incubator Model to Develop Powerful Biotech and Medtech Portfolio

Providing invaluable support to promising startups sets HLTT apart as early-stage companies work to break with tradition, launch their own products Playing a strategic role during critical phases of company life-cycles is a key approach that Healthtech is confident will breed increased chances of success VarianBio joins MediScan, RevHeart as trio of innovative healthcare technology companies in HLTT portfolio A new trend is emerging in the world of drug development — a trend that Healthtech Solutions (OTC: HLTT) is intent on leveraging as it focuses on developing a strong portfolio model in biotech and medtech. That commitment to reinventing the incubator model…

Continue Reading

TuesdayJun 15, 2021 9:15 am

As Investments Opportunities Pile Up for Its Biotech Portfolio Model Strategy, Healthtech Solutions Inc. (HLTT) Taps New CEO After First Acquisition

Dr. Edward “Ned” Swanson has joined Healthtech as CEO, bringing decades of scientific, clinical, industry and capital markets experience, including founding NASDAQ-listed company, to HLTT Healthtech in recent months has committed to a portfolio strategy, where it will bring diverse group of healthtech companies forward Company acquired precision oncology company Varian Biopharmaceuticals Inc. (“VarianBio”) in May, adding it to their family of companies that already included MediScan and RevHeart The biotech portfolio model is hot, with over $5.5 billion in capital raised in the last six years Historically, biotech companies built value nearly exclusively with a straightforward approach centered on…

Continue Reading

MondayJun 14, 2021 11:46 am

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Building Unique Structure to Bring Innovative Biotech to Market

Healthtech Solutions (OTC: HLTT) was featured in a recent article regarding its strategic appointment of CEO Edward Swanson, MD, who brings a broad array of scientific, clinical and industry specific expertise. The piece also highlighted the company’s focus to adopt a unique, portfolio-style business model. HLTT’s latest acquisition of Varian Biopharmaceuticals Inc., a precision oncology company developing novel therapeutics for the treatment of cancer, will add to its growing health care portfolio. To date, in addition to Varian Biopharmaceuticals, Healthtech Solutions is also the parent company to cloud-based ultrasound technology provider, MediScan Inc., as well as RevHeart Inc., a wholly…

Continue Reading

FridayJun 04, 2021 9:00 am

Healthtech Solutions Inc. (HLTT) Enters Precision Oncology Market with Acquisition of Varian Biopharmaceuticals

Ability to tailor diagnostics, therapeutics to specific patients is key to precision medicine Global precision oncology market projected to grow at CAGR of 9.9% over the next eight years, will reach $99.7 billion by 2027 Varian Bio making significant headway in development of two preclinical experimental cancer drugs Healthtech Solutions (OTC: HLTT) is making a strong statement with its most recent acquisition. HLTT acquired Varian Biopharmaceuticals, a precision oncology company developing novel therapeutics for the treatment of cancer —and with the acquisition, the company is making its entry into the precision cancer care market (https://ibn.fm/IaAcf).  “Precision medicine is a concept that…

Continue Reading

WednesdayJun 02, 2021 9:00 am

Healthtech Solutions Inc. (HLTT) Announces Appointment of Edward Swanson, MD as Company CEO

Dr. Swanson most recently co-founder of publicly listed PolarityTE, a biotech company focused around developing regenerative tissue products, biomaterials Prior to PolarityTE, Dr. Swanson served as resident in plastic and reconstructive surgery at John Hopkins University School of Medicine Healthtech Solutions has adopted a unique portfolio business model, recently announcing acquisition of precision oncology company Varian Biopharmaceuticals Healthtech Solutions (OTC: HLTT), the parent company of Varian Biopharmaceuticals Inc., Medi-Scan Inc. and RevHeart Inc., have recently announced the appointment of Edward Swanson, MD as the company’s new Chief Executive Officer (https://ibn.fm/444X7). The appointment, which is effective as of May 14, 2021,…

Continue Reading

MondayMay 17, 2021 11:00 am

QualityStocksNewsBreaks – Healthtech Solutions Inc. (HLTT) Announces Strategic CEO Appointment

Healthtech Solutions (OTC: HLTT), the parent company of Varian Biopharmaceuticals Inc., Medi-Scan Inc. and RevHeart Inc., has announced its appointment of Edward (“Ned”) Swanson, M.D., as its chief executive officer. Dr. Swanson brings a unique background and skillset that is particularly well suited to lead Healthtech, combining scientific, clinical and industry knowledge. He is a co-founder of PolarityTE Inc., a biotech company developing various regenerative tissue products and biomaterials, led by its flagship product SkinTE(R). In his leadership roles with PolarityTE and its subsidiaries, Dr. Swanson gleaned deep industry knowledge and know-how related to company formation, financing, product development, medical…

Continue Reading

FridayMay 14, 2021 1:39 pm

QualityStocksNewsBreaks – Healthtech Solutions Inc.’s (HLTT) Latest Acquisition Brings in Innovative Team of Experts

Healthtech Solutions (OTC: HLTT), focused on acquiring and investing in strategic cutting-edge health care technological opportunities, is among biotech players that have pivoted to a new model wherein multiple portfolio companies operate under one parent organization. Healthtech’s latest acquisition, Varian Biopharmaceuticals, brings to three the number of subsidiaries under its umbrella. “The acquisition of Varian by Healthtech plays to the strengths of the new portfolio model not only in drug pipeline but also by bringing in experts in an area that could attract additional investment,” reads a recent article. A precision oncology company, Varian specializes in developing atypical protein kinase…

Continue Reading

MondayMay 03, 2021 12:32 pm

Healthtech Solutions Inc. (HLTT) Adopts New Portfolio Model with Varian Bio Acquisition

McKinsey & Company notes that portfolio model is growing in popularity amongst companies and investors HLTT recently acquired precision oncology company Varian Biopharma Report shows that more than $5.5 billion in capital has been raised in past six years by companies with biotech portfolio models An emerging trend in biotechnology involves abandoning a single shot on goal approach in favor of a broader strategy with different portfolio companies under one umbrella. The old incubator approach with a new flare, the trend involves a portfolio manager utilizing a variety of skillsets to assemble a group of subsidiaries, each committed to a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered